Home / COVID-19 Briefing Series: European HCP Perspectives

Highlights from Trinity’s Recent Research Focused on European HCP

The COVID-19 pandemic continues to have an unprecedented impact on our lives and is disrupting businesses as it spreads worldwide.

As the EU5 countries comprise some of the most important pharmaceutical markets, and with Italy, Spain and France includes countries which have been impacted significantly from COVID-19, Trinity aimed to understand the impact on HCP engagement with Market Research.

Thank you for connecting with TRINITY.

Please read TRINITY’s white paper:

European HCP Perspectives